Cochlear Implantation — NCD 245 | CMS Coverage Update

TL;DR: The Centers for Medicare & Medicaid Services modified NCD 245 governing cochlear implantation coverage, with a policy review date of September 2022 and a document update effective January 9, 2026. Here's what billing teams need to know.

CMS cochlear implantation coverage policy under NCD 245 Medicare sets strict medical necessity criteria for bilateral sensorineural hearing loss. The policy does not list specific CPT or HCPCS codes, but the clinical criteria and coverage rules directly drive claim approval and denial decisions for cochlear implant procedures billed to Medicare. If your practice or ASC bills for cochlear implants, this policy is your blueprint.

Quick-Reference Table

CMS Cochlear Implantation Coverage Criteria and Medical Necessity Requirements 2026

The coverage policy under NCD 245 is built around one central test: does the patient demonstrate limited benefit from amplification? CMS defines that threshold precisely — a score of 60% or less on recorded tests of open-set sentence recognition in the best-aided listening condition. That number is your hard line. A score of 61% means the patient does not meet the Medicare coverage threshold, full stop.

Beyond the hearing test score, CMS requires patients to meet all five criteria listed in Section B. Every one. Not most of them — all of them. This is where claims get denied, and where your documentation needs to be bulletproof.

The five criteria are:

The third criterion is where most documentation gaps appear. "Freedom from middle ear infection" and "accessible cochlear lumen" require specific pre-operative imaging and ENT evaluation notes. If the chart doesn't explicitly document these findings, your claim is exposed.

The coverage policy also specifies the hearing loss must be bilateral, pre- or post-linguistic, and sensorineural in origin. Conductive or mixed hearing loss does not meet the NCD 245 Medicare coverage standard. Flag that in your intake checklist.

NCD 245 does not mention prior authorization requirements at the national level, but your Medicare Administrative Contractor may impose local requirements on top of this NCD. Check with your MAC before assuming blanket approval. Some MACs have local coverage determinations or LCDs that add documentation requirements beyond what CMS states here.

Cochlear implant billing under this policy is high-dollar. Reimbursement for these procedures can run into the tens of thousands of dollars when you include the device, surgical facility, and professional components. That makes a claim denial not just annoying — it's a significant revenue hit. Get the documentation right on the front end.

CMS Cochlear Implantation Exclusions and Non-Covered Indications

Section C of NCD 245 is short but important. Any Medicare beneficiary who does not meet all five criteria in Section B is not eligible for standard Medicare coverage. There's no partial credit here.

The real issue is what Section C doesn't say. It doesn't give you an appeals pathway for borderline cases under standard coverage rules. If a patient scores 62% on open-set sentence recognition, they fall outside the covered indication — even if every other clinical factor points toward cochlear implantation being appropriate.

Section D carves out one exception. CMS will cover cochlear implants for beneficiaries who don't meet Section B criteria if the procedure is performed within an FDA-approved Category B investigational device exemption (IDE) clinical trial, as defined at 42 CFR 405.201. Coverage is also available as a routine cost in clinical trials under Section 310.1 of the National Coverage Determinations Manual.

This is a narrow exception. Don't apply it broadly. If your patient is enrolled in an applicable clinical trial, your billing team and compliance officer need to document the trial enrollment explicitly on the claim. Billing a non-qualifying case under the clinical trial exception without proper documentation is an audit risk you don't want.

Coverage Indications at a Glance

CMS Cochlear Implantation Billing Guidelines and Action Items 2026

This policy is not a new one — the clinical criteria have been in place since September 26, 2022. But a January 9, 2026 document update means CMS has refreshed this NCD, and that's a signal to audit your processes now. Here's what to do before your next cochlear implant case.

1. Build the five-point checklist into your pre-authorization workflow.
Don't wait for the surgeon to document this at time of service. Create a pre-surgical checklist that captures all five Section B criteria. Every criterion needs explicit language in the chart — not implied, not inferred.

2. Pull the audiologic test report and verify the score.
The 60% threshold on open-set sentence recognition is objective and documented. Make sure the audiology report is in the file, the test used was a recorded (not live-voice) test, and the score reflects the best-aided listening condition. Live-voice testing does not meet the NCD standard.

3. Confirm bilateral, sensorineural diagnosis in the ICD-10 coding.
Your diagnosis codes must reflect bilateral sensorineural hearing loss. Unilateral codes or codes for conductive loss will fail medical necessity review. Coordinate with your coding team on diagnosis code selection before the claim goes out.

4. Check your MAC for local coverage determinations.
NCD 245 sets the national floor. Your Medicare Administrative Contractor may have an LCD that adds documentation requirements, prior authorization steps, or coding instructions on top of the NCD. Pull your MAC's current guidance and compare it to NCD 245 as part of your effective date January 9, 2026 audit.

5. Document clinical trial enrollment separately if applicable.
If you're billing under the Section D clinical trial exception, the claim must clearly reflect trial enrollment and the applicable trial identifier. This is not a standard cochlear implant billing path. Loop in your compliance officer before submitting claims under this exception — the documentation requirements are specific and the audit exposure is real.

6. Review your charge capture against FDA labeling requirements.
The device used must comply with FDA-approved labeling. If your implant program uses devices off-label in any way, that's a coverage exclusion under the NCD. Your medical director and compliance officer need to sign off on the device use documentation before billing.

CPT, HCPCS, and ICD-10 Codes for Cochlear Implantation Under NCD 245

NCD 245 does not list specific CPT, HCPCS, or ICD-10 codes in the policy document. This is unusual for a high-dollar surgical procedure and it creates a real documentation burden for cochlear implant billing teams.

The absence of specific codes in the NCD means your coding decisions rely on standard CPT guidelines, MAC-level coding instructions, and CMS claims processing transmittals. CMS has issued two claims processing transmittals relevant to this policy: TN 11875 and TN 11929. Your billing team should pull both documents and review the coding instructions there.

Common CPT codes associated with cochlear implantation — such as those for the surgical procedure, device programming, and fitting — are not enumerated in NCD 245 itself. Your Medicare Administrative Contractor's LCD or billing article is your best source for the specific codes your MAC recognizes for cochlear implant claims.

What this means for your billing team: You are responsible for ensuring your codes align with the coverage criteria in NCD 245 and any MAC-specific guidance. Gaps between NCD criteria and local MAC coding instructions are a common source of claim denial in cochlear implant billing. If you're not sure how your MAC has operationalized NCD 245, call the MAC's provider relations line directly. Don't guess.

If your MAC has not issued a local coverage determination for cochlear implantation, the NCD 245 criteria govern your claim at face value. Document accordingly.